Adrenomed appoints Dr. Stephan Witte as Chief Medical Officer
Hennigsdorf/Berlin (Germany), February 1, 2023 – Adrenomed AG, the vascular integrity company, today announced the appointment of Dr. Stephan Witte as Chief Medical Officer (CMO) of Adrenomed. Dr. Stephan Witte is a drug development professional
1. February 2023